Puma Biotechnology (PBYI) EBITDA Margin (2017 - 2026)
Puma Biotechnology's EBITDA Margin came in at 17.88% for Q2 2026, down 0.05 percentage points from 17.92% a year earlier but up 20.65 percentage points from the prior quarter.
Powered by 
Analysis
Puma Biotechnology (PBYI) EBITDA Margin (2017 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Puma Biotechnology reported EBITDA Margin of 17.69%, down 6.39 percentage points year-over-year; for FY2025, it was 21.12%, up 2.69 percentage points from FY2024.
- EBITDA Margin carries a five-year change of +30.17 percentage points (FY2020 to FY2025).
- Going back by year, EBITDA Margin was 18.44% in FY2024 (-0.30 pp), 18.74% in FY2023 (+4.02 pp), 14.72% in FY2022 (+9.74 pp) and 4.98% in FY2021 (+14.02 pp).
- The five-year range for quarterly EBITDA Margin is -14.08% (Q3 2021) to 30.99% (Q3 2024).
- Year-over-year, EBITDA Margin has declined for four consecutive quarters, with an average year-over-year change of +2.00 percentage points over the last eight quarters.
- The fastest year-over-year change in EBITDA Margin over five years came in Q2 2022 (a gain of 50.05 percentage points), and the weakest in Q1 2022 (a drop of 19.79 percentage points).
- Business Quant data shows PBYI's EBITDA Margin at -2.78% (Q1 2026), 26.19% (Q4 2025) and 22.57% (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 645.01 Bn | 563.54 Bn | 17.26 Bn | 35.95% |
| 2 | AbbVie | 465.23 Bn | 438.39 Bn | 12.70 Bn | 49.01% |
| 3 | Merck | 368.40 Bn | 322.83 Bn | 12.21 Bn | 6.02% |
| 4 | Novartis Ag | 278.02 Bn | 233.89 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 254.57 Bn | 228.13 Bn | 12.86 Bn | 33.11% |
| 6 | Amgen | 229.02 Bn | 184.42 Bn | 7.24 Bn | 46.01% |
| 7 | Gilead Sciences | 187.74 Bn | 161.85 Bn | 6.22 Bn | -124.26% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 39.16% |
| 9 | Vertex Pharmaceuticals | 133.45 Bn | 105.45 Bn | 2.84 Bn | 39.10% |
| 10 | Puma Biotechnology | 499.78 Mn | 112.42 Mn | 44.03 Mn | 17.88% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 17.88% |
| Mar 31, 2026 | -2.78% |
| Dec 31, 2025 | 26.19% |
| Sep 30, 2025 | 22.57% |
| Jun 30, 2025 | 17.92% |
| Mar 31, 2025 | 14.74% |
| Dec 31, 2024 | 27.43% |
| Sep 30, 2024 | 30.99% |
| Jun 30, 2024 | 1.55% |
| Mar 31, 2024 | 1.37% |
| Dec 31, 2023 | 24.50% |
| Sep 30, 2023 | 20.42% |
| Jun 30, 2023 | 14.24% |
| Mar 31, 2023 | 13.72% |
| Dec 31, 2022 | 18.99% |
| Sep 30, 2022 | 8.51% |
| Jun 30, 2022 | 24.39% |
| Mar 31, 2022 | 3.74% |
| Dec 31, 2021 | 17.72% |
| Sep 30, 2021 | -14.08% |
API Access
Puma Biotechnology EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "PBYI", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=PBYI&period=max&api_key=YOUR_API_KEY");
const data = await res.json();